fu li
National Engineering Research Center for Natural Medicine, Chengdu Institute of Biology, Chinese Academy of Sciences (CAS)
Chengdu, China
Review Editor
Inflammation Pharmacology
National Engineering Research Center for Natural Medicine, Chengdu Institute of Biology, Chinese Academy of Sciences (CAS)
Chengdu, China
Review Editor
Inflammation Pharmacology
Shandong University of Traditional Chinese Medicine
Jinan, China
Review Editor
Inflammation Pharmacology
The Second Affiliated Hospital, Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, China
Review Editor
Inflammation Pharmacology
East China University of Science and Technology
Shanghai, China
Review Editor
Inflammation Pharmacology
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland
St Lucia, Australia
Review Editor
Inflammation Pharmacology
Merck Sharp & Dohme Corp (United States)
West Point, United States
Review Editor
Inflammation Pharmacology
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Inflammation Pharmacology
Hunan University of Chinese Medicine
Changsha, China
Review Editor
Inflammation Pharmacology
National University of Singapore
Singapore, Singapore
Review Editor
Inflammation Pharmacology
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Review Editor
Inflammation Pharmacology
University of Santiago de Compostela
Santiago de Compostela, Spain
Review Editor
Inflammation Pharmacology
Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University
Wenzhou, China
Review Editor
Inflammation Pharmacology
RMIT University
Melbourne, Australia
Review Editor
Inflammation Pharmacology
Ocean University of China
Qingdao, China
Review Editor
Inflammation Pharmacology
Third Clinical Medical College, Nanjing Medical University
Nanjing, China
Review Editor
Inflammation Pharmacology
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Review Editor
Inflammation Pharmacology